ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2045 • ACR Convergence 2023

    Treatment Response in a Cohort of Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV)

    Ilaria Maccora1, Arjun Sood2, Grant Schulert3, Alexandra Duell3, Preston Land4, Cameron C Sapp2, Jennifer Huggins3, Tiffany Nguyen2, Megan Quilan-Waters3, Sumit Sharma5, Sunil Srivastava2 and Sheila Angeles-Han6, 1PhD student, in the Area of Drugs and Innovative Treatments, NeuroFARBA Department, University of Florence. Meyer Children's Hospital, Firenze, Italy, 2Cincinnati Eye Institute, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital, Medical Center, Cincinnati, OH, 5Cleveland Clinic, Cleveland, OH, 6Cincinnati Children's Hospital, Cincinnati, OH

    Background/Purpose: Pediatric uveitis often requires systemic immunomodulatory therapy (IMT) to prevent sight-threatening complications. Autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV) is a rare autoimmune condition caused…
  • Abstract Number: 1850 • ACR Convergence 2023

    Long-term Glucocorticoid Use in a Cohort of Elderly Early Rheumatoid Arthritis Patients: A Joint Analysis of Medicare and the Rheumatology Informatics System for Effectiveness (RISE) Data

    Andriko Palmowski1, Eric Roberts2, Jing Li2, Emma Kersey2, Rachael Stovall2, Frank Buttgereit3, Jinoos Yazdany4 and Gabriela Schmajuk5, 1Charité - Universitätsmedizin Berlin, Berlin, Germany, 2University of California San Francisco, San Francisco, CA, 3Charité Universitätsmedizin, Dept. Rheumatology, Berlin, Germany, 4University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 5UCSF / SFVA, San Francisco, CA

    Background/Purpose: According to recent ACR and EULAR rheumatoid arthritis (RA) guidelines, glucocorticoids (GCs) should only be used for brief periods or not at all. Our…
  • Abstract Number: 2077 • ACR Convergence 2023

    A Curriculum of Online Education Significantly Improved Rheumatologists’ Knowledge, Competence and Confidence in Managing Patients with Spondyloarthritis

    Elaine Bell1, Marinella Calle2 and Iain McInnes3, 1Medscape Global Education, London, United Kingdom, 2MEDSCAPE GLOBAL, London, United Kingdom, 3University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are challenging conditions for rheumatologists to manage. There is an increasing focus on virtual training modalities post-pandemic.…
  • Abstract Number: 1974 • ACR Convergence 2023

    Comparison of Gait Spatiotemporal Measures Between Patients with Insertional Achilles Tendinopathy or Midportion Achilles Tendinopathy

    Hayley Smitheman1, Kayla Seymore1, Andy Smith1, Morgan Potter1, Nabeel Alghamdi1 and Karin Silbernagel2, 1University of Delaware, Newark, DE, 2University of Delaware, Avondale, PA

    Background/Purpose: Insertional and midportion Achilles tendinopathy (AT) are painful injuries affecting both active and sedentary populations. Patients with AT present with pain with loading, often…
  • Abstract Number: 2079 • ACR Convergence 2023

    Comparative Analysis of Teledidactic and On-Campus Training in Musculoskeletal Ultrasound – the TELMUS Study

    Ricarda Neubauer1, Florian Recker2, Claus Juergen Bauer3, Simon Petzinna1, Pantelis Karakostas3, Charlotte Behning4 and Valentin Sebastian Schäfer3, 1Clinic of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Bonn, Germany, 2Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany, 3Clinic of Internal Medicine III, Department of Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, Bonn, Germany, 4Institute of Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, Bonn, Germany

    Background/Purpose: Musculoskeletal ultrasound (MSUS) plays a vital role as a diagnostic imaging modality in rheumatology, while also serving as an effective teaching tool to enhance…
  • Abstract Number: 2047 • ACR Convergence 2023

    Safety of Baricitinib for COVID-19 Related Hyperinflammation in Pediatric Patients: A Large Tertiary Care Center Experience

    Meredith Rae1, Jessica Nguyen2, Marietta DeGuzman3, Catherine Foster1, Flor Munoz1 and Eyal Muscal4, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Manvel, TX, 3Baylor College of Medicine / Texas Children's Hospital, Houston, TX, 4Division of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, TX

    Background/Purpose: A small proportion of children with acute COVID-19 experienced life-threatening hyperinflammation. It has been proposed that an innate immune recognition of viral RNA triggers…
  • Abstract Number: 1983 • ACR Convergence 2023

    Heated Mittens for Patients with Hand Osteoarthritis: A Randomized Trial

    Cecilie Bartholdy1, Anna Døssing2, Zara Stisen1, Sabrina Mai Nielsen3, Henning Bliddal1, Robin Christensen4, Marius Henriksen1 and Karen Ellegaard1, 1The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 2The Parker Institutte, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 3The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 4Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Denmark

    Background/Purpose: Hand Osteoarthritis (OA) is common and causes pain and disability. Heat is anecdotally known to moderate symptoms and is conditionally recommended as a treatment…
  • Abstract Number: 1856 • ACR Convergence 2023

    Improving Recombinant Zoster Vaccination Rates in Patients Receiving Immunosuppressive Therapy in the Rheumatology Clinic at the Orlando VA Healthcare System – a Quality Improvement Project

    Kathlyn Camargo Macias1, Ravi Shahu Khal1, Ariail Schmitz2, Kathleen McCabe1, Taylor Kann1, Marilyn Mosquera3 and Ashwini Komarla4, 1University of Central Florida, Orlando, FL, 2University of Central Florida, St. Cloud, FL, 3University of Central Florida, Casselberry, FL, 4ORLANDO VAMC, Orlando, FL

    Background/Purpose: Herpes zoster is a painful rash that involves one to three adjacent dermatomes, secondary to reactivation of latent varicella-zoster virus (VZV). About 95 %…
  • Abstract Number: 1239 • ACR Convergence 2023

    Clinical Manifestations and Management of Takayasu Arteritis: A Multicenter Pediatric Cohort

    Ana Luiza Altaffer1, Kristina Ciaglia2, Elizabeth Sloan3 and Marietta De Guzman4, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2UT Southwestern and Scottish Rite for Children, Dallas, TX, 3UT Southwestern, Dallas, TX, 4Baylor College of Medicine, Houston, TX

    Background/Purpose: Takayasu arteritis (TA) is a rare granulomatous vasculitis that affects large vessels, including the aorta, its major branches, and the pulmonary artery. Data on…
  • Abstract Number: 1843 • ACR Convergence 2023

    Detection of Clinically Relevant Subgroups in Patients Undergoing Knee Replacement Using Machine Learning

    Brooke McGinley1, Gabriela Rabasa1, Jean Liew1, Tuhina Neogi2, David Felson1 and Michael LaValley3, 1Boston University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA

    Background/Purpose: In the US the lifetime risk for Knee Replacement surgery (KR) is 7% for men and 9.5% for women, and this accounts for substantial…
  • Abstract Number: 1331 • ACR Convergence 2023

    Long-term Effectiveness of a Lifestyle Program for Rheumatoid Arthritis: One-year Follow-up of the “Plants for Joints” Randomized Clinical Trial

    Carlijn Wagenaar1, Wendy Walrabenstein1, Marike Van der Leeden2, Franktien Turkstra2, Jos W.R. Twisk1, Maarten Boers1, Henriët van Middendorp3, Peter Weijs4 and Dirkjan van Schaardenburg5, 1Amsterdam University Medical Centers, Amsterdam, Netherlands, 2Reade Rheumatology Center, Amsterdam, Netherlands, 3Leiden University, Leiden, Netherlands, 4Amsterdam University of Applied Sciences, Amsterdam, Netherlands, 5Reade, Amsterdam, Netherlands

    Background/Purpose: The 16-week Plants for Joints (PFJ) multidisciplinary lifestyle program, based on a whole-food plant-based diet, physical activity, and stress management, significantly reduced 28-joint Disease…
  • Abstract Number: 1254 • ACR Convergence 2023

    Outcome of Pediatric Lupus in South Asia: Data from Indian SLE Inception Cohort for Research (INSPIRE)

    Amita Aggarwal1, Ranjan Gupta2, Liza Rajasekhar3, Ashish J Mathew4, Parasar Ghosh5, Chengappa Kavadichanda6, Vineeta Shobha7, Bidyut Das8, Manish Rathi9, Avinash Jain10 and Able Lawrence1, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India, 2All India Institute of Medical Sciences, New Delhi, India, 3Nizam's Institute of Medical Sciences, Madhapur, India, 4Christian Medical College, Vellore, India, 5Govt of West Bengal, Kolkata, India, 6Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India, 7St. John's National Academy of Health Science, Bangalore, India, 8SCB medical college, Cuttack, India, 9Postgraduate Institute of Medical education and Research, Chandigarh, India, 10SMS Medical College, Lucknow, India

    Background/Purpose: Juvenile onset SLE (jSLE) has more severe disease and has poorer outcome as compared to adults SLE. Ethnicity affects clinical course and disease outcome…
  • Abstract Number: 1341 • ACR Convergence 2023

    Impact of Ultrasound on Physician Assessments of Patients with RA with Elevated Clinical Disease Activity Scores

    Stephanie Song1, Odette Kolenky1, Antje Greenfield2, Dana Direnzo3, Joshua Baker4 and Michael George4, 1Hospital of the University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania Health System, Philadelphia, PA, 3University of Pennsylvania, Bala Cynwyd, PA, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Treat-to-target is recommended in RA, but physicians often do not escalate therapy despite elevated disease activity measures due to uncertainty regarding the true degree…
  • Abstract Number: 1852 • ACR Convergence 2023

    Human Papillomavirus Vaccine Uptakes in Ethnically Diverse Women Living with Systemic Lupus Erythematosus

    Sebastian Bruera1, Yinan Huang2, Savannah Bowman1, Maria Suarez-Almazor3, Grace Lo1, Maria A. Lopez-Olivo4 and Sandeep Agarwal1, 1Baylor College of Medicine, Houston, TX, 2Department of Pharmacy Administration, University of Mississippi School of Pharmacy, Oxford, MS, 3MD Anderson Cancer Center, Houston, TX, 4The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Women with systemic lupus erythematosus are at an increased risk of infections from the human papillomavirus (HPV) and subsequently HPV-mediated malignancies and genital warts.…
  • Abstract Number: 1863 • ACR Convergence 2023

    Immune-mediated Hypertrophic Pachymeningitis: Focusing on the Localization and Volume of Thickened Dura Mater Lesion

    Yasuhiro Shimojima1, Junji Ikeda2 and Yoshiki Sekijima1, 1Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan, 2Department of Medicine (Neurologu and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan

    Background/Purpose: Hypertrophic pachymeningitis (HP) is a rare inflammatory neurological disorder characterized by the thickened dura mater with extensive tissue fibrosis and immune-mediated inflammation. Notably, headaches…
  • « Previous Page
  • 1
  • …
  • 300
  • 301
  • 302
  • 303
  • 304
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology